Yosef Blaer
Department of Cardiology, Barzilai University Medical Center, Ashkelon, Israel.
Title: Transient Ventricular Fibrillation, is it a real possibility?
Biography
Biography: Yosef Blaer
Abstract
At least 400,000 people in the United States die suddenly every year from coronary heart disease (CHD). The leading cause of cardiac death is malignant arrhythmia such as ventricular fibrillation (VF). The precipitating causes are poorly understood. VF in humans is generally sustained (SVF) which results in death, unless effective artificial defibrillation is applied within minutes. Spontaneous reverting of VF to sinus rhythm is very rare. Sporadic cases of transient ventricular fibrillation (TVF) reported in English literature. The description of human TVF is rare clinically and can be founded in sporadic cases unrelated to any known cardiac or non-cardiac etiology: triggered automatically, idiopathic, local cardiac activation, structurally normal human heart. The same authors described that the cardiologists offered self-terminating VF to 15.6% of ventricular tachyarrhythmias. The AHA/ACC guidelines don't specify the ideal professional level of the monitor watcher, but highly recommend that staff receive formal education related to the monitoring system, goals of monitoring, and ECG interpretation. Early recognition of lethal dysrhythmias and quick action give the patient a best chance to survive. Finally, it is well-established fact, that arrhythmia monitoring with immediately available defibrillation has improved survival and patient outcomes. A TVF may represent in some patients in clinical practice. The patient survive "silent", un witnessed TVF remained at risk for sudden death and a preventive therapy must be established.